---
figid: PMC9710321__mca-0005-0207-g02
pmcid: PMC9710321
image_filename: mca-0005-0207-g02.jpg
figure_link: /pmc/articles/PMC9710321/figure/F2/
number: Fig. 2
figure_title: ''
caption: Molecular targets for cannabidiol (CBD) in Alzheimer's disease (AD). Cannabinoid
  receptors (CB1/CB2), transient receptor potential cation channel subfamily V member
  1 (TRPV1), Wnt/GSK-3β (Wnt/glycogen synthase kinase 3 beta pathway), amyloid precursor
  protein (APP), beta-amyloid (Aβ) peptide, peroxisome proliferator-activated receptors
  (PPARγ), beta-catenin (β-catenin), neurofibrillary tangles (NFTs), nuclear factor
  kappa-light-chain-enhancer of activated B cells (NF-κB), tau protein (TAU), reactive
  oxygen species (ROS).
article_title: 'Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment
  of Neurodegenerative Diseases?.'
citation: Milena de Barros Viana, et al. Med Cannabis Cannabinoids. 2022 Jan-Dec;5(1):207-219.
year: '2022'

doi: 10.1159/000527335
journal_title: Medical Cannabis and Cannabinoids
journal_nlm_ta: Med Cannabis Cannabinoids
publisher_name: S. Karger AG

keywords:
- Cannabis sativa
- Cannabidiol
- Neurodegeneration
- Neuroprotection

---
